1-6 of 6
Archana S. Nagaraja
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P260: Development and validation of a novel T-cell modulating, microbiome-based peptide for combination with immunotherapy

Michelle Lin, Archana S. Nagaraja, Dhwani Haria, Yuliya Katlinskaya, Divya Ravichandar, Preston Williams, Roberta Hannibal, Todd Z. DeSantis, Bum-Yeol Hwang, Michi Wilcoxon, Toshi Takeuchi, Karim Dabbagh, Preeti Lal, Helena Kiefel
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12_Supplement): P260.
https://doi.org/10.1158/1535-7163.TARG-21-P260
Published: 01 December 2021
View article titled, Abstract P260: Development and validation of a novel T-cell modulating, microbiome-based peptide for combination with immunotherapy
Journal Articles

SENTI-101, a Preparation of Mesenchymal Stromal Cells Engineered to Express IL12 and IL21, Induces Localized and Durable Antitumor Immunity in Preclinical Models of Peritoneal Solid Tumors

Alba Gonzalez-Junca, Frances D. Liu, Archana S. Nagaraja, Alyssa Mullenix, Chen-Ting Lee, Russell M. Gordley, Daniel O. Frimannsson, Ori Maller, Brian S. Garrison, Dharini Iyer, Anissa Benabbas, Tiffany A. Truong, Allison Quach, Mengxi Tian, Rowena Martinez, Rishi Savur, Alyssa Perry-McNamara, Denny Nguyen, Niran Almudhfar, Carmina Blanco, Christina Huynh, Asish Nand, Yu-An E. Lay, Ashita Magal, Sravani Mangalampalli, Philip J. Lee, Timothy K. Lu, Gary Lee
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (9): 1508–1520.
https://doi.org/10.1158/1535-7163.MCT-21-0030
Published: 01 September 2021
View article titled, SENTI-101, a Preparation of Mesenchymal Stromal Cells Engineered to Express IL12 and IL21, Induces Localized and Durable Antitumor Immunity in Preclinical Models of Peritoneal Solid Tumors
Open the PDF for SENTI-101, a Preparation of Mesenchymal Stromal Cells Engineered to Express IL12 and IL21, Induces Localized and Durable Antitumor Immunity in Preclinical Models of Peritoneal Solid Tumors in another window
Includes: Supplementary data
Journal Articles

PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer

Takeshi Hisamatsu, Michael McGuire, Sherry Y. Wu, Rajesha Rupaimoole, Sunila Pradeep, Emine Bayraktar, Kyunghee Noh, Wei Hu, Jean M. Hansen, Yasmin Lyons, Kshipra M. Gharpure, Archana S. Nagaraja, Lingegowda S. Mangala, Takashi Mitamura, Cristian Rodriguez-Aguayo, Young Gyu Eun, Johnathon Rose, Geoffrey Bartholomeusz, Cristina Ivan, Ju-Seog Lee, Koji Matsuo, Michael Frumovitz, Kwong K. Wong, Gabriel Lopez-Berestein, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (1): 162–172.
https://doi.org/10.1158/1535-7163.MCT-17-1050
Published: 02 January 2019
View article titled, <em>PRKRA</em>/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer
Open the PDF for <em>PRKRA</em>/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer

Yan Huang, Wei Hu, Jie Huang, Fangrong Shen, Yunjie Sun, Cristina Ivan, Sunila Pradeep, Robert Dood, Monika Haemmerle, Dahai Jiang, Lingegowda S. Mangala, Kyunghee Noh, Jean M. Hansen, Heather J. Dalton, Rebecca A. Previs, Archana S. Nagaraja, Michael McGuire, Nicholas B. Jennings, Russell Broaddus, Robert L. Coleman, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (2): 464–473.
https://doi.org/10.1158/1535-7163.MCT-17-0006
Published: 01 February 2018
View article titled, Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer
Open the PDF for Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer in another window
Includes: Supplementary data
Journal Articles

Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth

Jie Huang, Wei Hu, Limin Hu, Rebecca A. Previs, Heather J. Dalton, Xiao-Yun Yang, Yunjie Sun, Michael McGuire, Rajesha Rupaimoole, Archana S. Nagaraja, Yu Kang, Tao Liu, Alpa M. Nick, Nicholas B. Jennings, Robert L. Coleman, Robert B. Jaffe, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (6): 1344–1352.
https://doi.org/10.1158/1535-7163.MCT-15-0144
Published: 02 June 2016
View article titled, Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth
Open the PDF for Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth in another window
Includes: Supplementary data
Journal Articles

Therapeutic Silencing of KRAS Using Systemically Delivered siRNAs

Chad V. Pecot, Sherry Y. Wu, Seth Bellister, Justyna Filant, Rajesha Rupaimoole, Takeshi Hisamatsu, Rajat Bhattacharya, Anshumaan Maharaj, Salma Azam, Cristian Rodriguez-Aguayo, Archana S. Nagaraja, Maria Pia Morelli, Kshipra M. Gharpure, Trent A. Waugh, Vianey Gonzalez-Villasana, Behrouz Zand, Heather J. Dalton, Scott Kopetz, Gabriel Lopez-Berestein, Lee M. Ellis, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (12): 2876–2885.
https://doi.org/10.1158/1535-7163.MCT-14-0074
Published: 04 December 2014
View article titled, Therapeutic Silencing of KRAS Using Systemically Delivered siRNAs
Open the PDF for Therapeutic Silencing of KRAS Using Systemically Delivered siRNAs in another window
Includes: Supplementary data